期刊
CURRENT DIABETES REVIEWS
卷 14, 期 3, 页码 201-221出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1573399813666170112142837
关键词
Type 2 diabetes; therapeutics; gut and brain derived molecules; adipokines; small molecule drugs; phytochemicals
资金
- Department of Biotechnology (DBT), New Delhi, India [BT/PR12584/MED/31/289/2014]
- University Grant Commission (UGC), New Delhi, India [UGC-NFST-2015-17-ST-GUJ-738]
Background: Diabetes has turned into a pandemic disorder that is affecting millions of people worldwide. Industries are aggressively racing and pursuing research towards the discovery of antidiabetic drug and the current global sale of such drugs are ever on the increase. However, in spite of such massive level of expenditure thereof, WHO projects that by 2030, diabetes will rank as the 7 th leading cause of mortality. Objective: It is in this context that we have reviewed here the various approaches available and possible towards diabetes management. This review also includes the WHO guidelines for controlling the glycemic levels, which must be known and followed by clinicians for a better diabetes management. Conclusion: Despite having a wealth of FDA-approved therapeutic options for type 2 diabetes majorities of the patients are not able to achieve the appropriate glycemic control due to various factors. The development of new options with actions at multiple foci of diabetic manifestation and better efficacy may potentially help in improving the current scenario of T2D management.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据